Srihari S. Naidu

Modified from Wikipedia: An academic interventional cardiologist, Naidu is an expert in the management of patients with hypertrophic cardiomyopathy, including the minimally-invasive alternative to surgery known as alcohol septal ablation. A co-author on the first ACC/AHA National Guideline on the Diagnosis and Management of Hypertrophic Cardiomyopathy in 2011, as well as the most recent version in 2024, he is editor of the international textbook on the disease, runs a Hypertrophic Cardiomyopathy Treatment Center following over 2000 patients, and has personally performed over 275 alcohol septal ablations, believed to be the largest case series of this procedure by a single-operator in the United States. Hypertrophic cardiomyopathy is the most common cause of sudden cardiac death among children and athletes, and an increasingly recognized cause of heart failure at all ages. Naidu is Director of the Cardiac Cath Lab and Hypertrophic Cardiomyopathy Center - with offices in Long Island and Westchester - at Westchester Medical Center in Valhalla, NY. He is a two-term Past Member of the American College of Cardiology (ACC) Interventional Scientific Council and has served on the Program Committee for the American Heart Association Annual Scientific Sessions. He is the author of over 200 original scientific manuscripts, and has authored clinical practice guidelines and consensus statements on behalf of the American College of Cardiology (ACC), American Heart Association (AHA) and the Society for Cardiovascular Angiography and Interventions (SCAI), including Chairing the Best Practices in the Cardiac Catheterization Laboratory document since 2012 that outlines operations for cardiac catheterization laboratories in the United States. Naidu is Founder and Past Chair of the Emerging Leader Mentorship (ELM) Program for SCAI (in partnership with ACC and the Cardiovascular Research Foundation), a national leadership pipeline initiated in 2010 that identifies and trains 12 interventional cardiologists every two years. Naidu is a 2-term Trustee of the SCAI, the primary international professional society for physicians specializing in interventional cardiology, and was inducted into the International Andreas Gruentzig Society (IAGS) in 2016. An alum of the Brown University 8-year Program in Liberal Medical Education, Naidu is Past President of the Alpert Medical School of Brown University Alumni Association Board of Directors, and a Trustee Emeritus of Brown University. In 2019, he was elected Governor and President of The New York State Chapter of the American College of Cardiology, and President of The New York Cardiological Society, which he continued until 2024. In 2021 he was named to the Top 100 Notable Leaders in NY Healthcare in Crain's New York Business for his work in the national cardiovascular response to COVID-19. In 2022, he was elected Secretary of SCAI, is currently President-Elect, and will be President from 2025-2026. Dr. Naidu's clinical passions include treating and raising awareness about Hypertrophic Cardiomyopathy. In his spare time, he collects comic book original art, watches the New York Knicks as a long time season ticket holder, and sings a capella.